Melford Chuka Egbujor
Melford Chuka Egbujor publishes mostly in Organic Chemistry, Molecular Biology and Materials Chemistry, on topics such as Synthesis and biological activity, Genomics, phytochemicals, and oxidative stress and Enzyme function and inhibition.
- World rank
- #1,860,401 of 7,710,434 ranked researchers
- Rank in Nigeria
- #2,105 of 26,141
- Works
- 40
- Citations
- 548
- Citations per work
- 13.7
What does Melford Chuka Egbujor research?
Melford Chuka Egbujor's work is mostly in Chemistry (34%), Biochemistry, Genetics and Molecular Biology (29%), Medicine (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1538.5%
- Chemistry1433.9%
- Materials Science24.6%
- Life Sciences1332.2%
- Everything else923.7%
- Health Sciences25.6%
- Medicine25.6%
- 1Organic Chemistry34% of their works
- 2Molecular Biology29% of their works
- 3Materials Chemistry5% of their works
- 4Plant Science3% of their works
- 5Pharmacology3% of their works
- 6Biochemistry3% of their works
Research topics
- Synthesis and biological activity
- Genomics, phytochemicals, and oxidative stress
- Enzyme function and inhibition
- Free Radicals and Antioxidants
- Phenothiazines and Benzothiazines Synthesis and Activities
- Inorganic and Organometallic Chemistry
- Corrosion Behavior and Inhibition
- Synthesis and Characterization of Heterocyclic Compounds
Which keywords describe Melford Chuka Egbujor's research?
The keywords of their largest research topics: Anticancer Agents, Oxidative Stress, Heterocyclic Compounds, Drug Discovery, Medicinal Chemistry, Tubulin Inhibitors, Keap1-Nrf2-ARE Pathway and Nrf2.
- Triazines
- Phenothiazines
- Metal Corrosion
- Catalysis
- Phenolic Compounds
- Synthesis
- Inhibitors
- Nrf2
- Tubulin Inhibitors
- Drug Discovery
- Oxidative Stress
- Anticancer Agents
- Heterocyclic Compounds
- Medicinal Chemistry
- Keap1-Nrf2-ARE Pathway
- Carbonic Anhydrases
- Antimicrobial
- Antioxidant
- Biological Activities
- Corrosion Inhibitors
- Organic Synthesis
- Biological Evaluation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Anticancer Agents222 topics
- Oxidative Stress182 topics
- Heterocyclic Compounds172 topics
- Drug Discovery132 topics
- Medicinal Chemistry121 topic
- Tubulin Inhibitors121 topic
- Keap1-Nrf2-ARE Pathway111 topic
- Nrf2111 topic
- Carbonic Anhydrases101 topic
- Inhibitors101 topic
- Antimicrobial82 topics
- Synthesis82 topics
- Antioxidant71 topic
- Phenolic Compounds71 topic
- Biological Activities51 topic
- Catalysis51 topic
- Corrosion Inhibitors51 topic
- Metal Corrosion51 topic
- Organic Synthesis51 topic
- Phenothiazines51 topic
- Biological Evaluation31 topic
- Triazines31 topic
Where does Melford Chuka Egbujor work?
Melford Chuka Egbujor's main affiliation in the publication record is Renaissance University, Nigeria.
How many publications and citations does Melford Chuka Egbujor have?
OpenAlex counts 40 works and 548 citations for Melford Chuka Egbujor, an h-index of 14, ranking #1,860,401 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Melford Chuka Egbujor. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.